West Pharmaceutical Services, Inc. (WST)

WST Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	435.8	791.3	484.6	853.9	894.3	762.6
Cash & Short-Term Investments	435.8	791.3	484.6	853.9	894.3	762.6
Cash Growth	-14.50%	63.29%	-43.25%	-4.52%	17.27%	23.90%
Receivables	729.2	586.3	575.8	533.5	523.7	503.6
Inventory	447.4	443.9	377	434.7	414.8	378.4
Other Current Assets	195.1	156.7	100.7	114.3	86.7	97.4
Total Current Assets	1,808	1,978	1,538	1,936	1,920	1,742
Property, Plant & Equipment	1,824	1,878	1,716	1,513	1,263	1,127
Long-Term Investments	207.7	212.3	202.1	210	204.9	207.7
Goodwill	108.7	109.9	106	108.5	107.3	109.9
Other Intangible Assets	6.4	7.7	10.8	15.1	18.4	23
Long-Term Deferred Tax Assets	72.3	38.4	26	25.7	65.6	48.5
Other Long-Term Assets	49.6	45.4	44.6	21.3	38.4	55.9
Total Assets	4,076	4,270	3,643	3,830	3,617	3,314

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	252.7	253.7	239.3	242.4	215.4	232.2
Accrued Expenses	131.1	214.6	138	161.3	145.8	186.1
Current Portion of Long-Term Debt	-	-	-	134	2.2	44.2
Current Portion of Leases	22.3	24.2	18.8	17.7	16	9.3
Current Income Taxes Payable	64.7	28.1	31.5	16.6	24.8	26.3
Current Unearned Revenue	-	51.9	49.6	41.7	57.3	48.7
Other Current Liabilities	169.7	82.4	73.2	58.1	57.5	47.3
Total Current Liabilities	640.5	654.9	550.4	671.8	519	594.1
Long-Term Debt	202.9	202.8	202.6	72.8	206.7	208.8
Long-Term Leases	91.3	99.2	83.9	84.5	93	63
Long-Term Unearned Revenue	-	1.8	3.6	12.2	10.9	-
Pension & Post-Retirement Benefits	28.3	29	28.2	29.6	28.2	40.5
Long-Term Deferred Tax Liabilities	22.4	23	20.5	12.7	14.3	4.9
Other Long-Term Liabilities	100.8	83.3	71.9	64.9	59.8	67.1
Total Liabilities	1,086	1,094	961.1	948.5	931.9	978.4

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	18.8	18.8	18.8	18.8	18.8	18.8
Additional Paid-In Capital	-	-	22.1	120.2	232.2	249
Retained Earnings	4,624	4,375	3,957	3,523	2,988	2,457
Treasury Stock	-1,512	-1,112	-1,057	-637.6	-370.9	-229.5
Comprehensive Income & Other	-140.4	-105.5	-258.1	-143.8	-183	-159.6
Shareholders' Equity	2,990	3,176	2,682	2,881	2,685	2,335
Total Liabilities & Equity	4,076	4,270	3,643	3,830	3,617	3,314

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	316.5	326.2	305.3	309	317.9	325.3
Net Cash (Debt)	119.3	465.1	179.3	544.9	576.4	437.3
Net Cash Growth	-40.79%	159.40%	-67.09%	-5.46%	31.81%	53.87%
Net Cash Per Share	1.65	6.40	2.43	7.24	7.60	5.73
Filing Date Shares Outstanding	70.38	72.02	72.3	73.3	74.14	74.28
Total Common Shares Outstanding	70.4	72	72.3	73.5	74.1	74.2
Working Capital	1,167	1,323	987.7	1,265	1,401	1,148
Book Value Per Share	42.47	44.11	37.10	39.20	36.23	31.47
Tangible Book Value	2,875	3,058	2,566	2,757	2,559	2,203
Tangible Book Value Per Share	40.84	42.48	35.48	37.52	34.54	29.68
Land	-	29.2	27.9	33.7	29	29.3
Buildings	-	1,181	916.1	771.5	663.6	644.8
Machinery	-	1,757	1,631	1,518	1,388	1,298
Construction In Progress	-	256.7	410.8	415.2	305.9	242.7

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Jul 23, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 24, 2026

Data Sources Report a data error